↓ Skip to main content

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

Overview of attention for article published in The Lancet, May 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Citations

dimensions_citation
335 Dimensions

Readers on

mendeley
511 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial
Published in
The Lancet, May 2018
DOI 10.1016/s0140-6736(18)31033-x
Pubmed ID
Authors

Nikola Sprigg, Katie Flaherty, Jason P Appleton, Rustam Al-Shahi Salman, Daniel Bereczki, Maia Beridze, Hanne Christensen, Alfonso Ciccone, Ronan Collins, Anna Czlonkowska, Robert A Dineen, Lelia Duley, Juan Jose Egea-Guerrero, Timothy J England, Kailash Krishnan, Ann Charlotte Laska, Zhe Kang Law, Serefnur Ozturk, Stuart J Pocock, Ian Roberts, Thompson G Robinson, Christine Roffe, David Seiffge, Polly Scutt, Jegan Thanabalan, David Werring, David Whynes, Philip M Bath, TICH-2 Investigators

X Demographics

X Demographics

The data shown below were collected from the profiles of 311 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 511 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 511 100%

Demographic breakdown

Readers by professional status Count As %
Other 71 14%
Researcher 57 11%
Student > Doctoral Student 43 8%
Student > Bachelor 37 7%
Student > Postgraduate 34 7%
Other 120 23%
Unknown 149 29%
Readers by discipline Count As %
Medicine and Dentistry 219 43%
Neuroscience 34 7%
Nursing and Health Professions 19 4%
Pharmacology, Toxicology and Pharmaceutical Science 14 3%
Psychology 7 1%
Other 39 8%
Unknown 179 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 465. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2023.
All research outputs
#59,959
of 25,882,826 outputs
Outputs from The Lancet
#1,026
of 43,064 outputs
Outputs of similar age
#1,340
of 343,756 outputs
Outputs of similar age from The Lancet
#22
of 370 outputs
Altmetric has tracked 25,882,826 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 43,064 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,756 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 370 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.